Dermapharm Holding SE buy investresearch
Summary
This prediction is currently active. The price of Dermapharm Holding SE has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.31%. This prediction currently runs until 31.10.24. The prediction end date can be changed by investresearch at any time. investresearch has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Dermapharm Holding SE | -2.025% | -2.025% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by investresearch for this prediction
In the thread Dermapharm Holding SE diskutieren